Skip to main content
Top

Reactions Weekly

Issue 1/2023

Content (539 Articles)

Case report

Amiodarone

Case report

Antineoplastics

Case report

Antineoplastics

Case report

Aumolertinib

Olanzapine Case report

BBV-152

Pneumonia Case report

BCG

Case report

Bleomycin/Cisplatin

Case report

Chlortalidone

Myalgia Case report

Diminazene

Case report

Enobosarm abuse

Fentanyl Case report

Fentanyl

Case report

Ferric-carboxymaltose

Heparin Case report

Heparin

Case report

Hydrocortisone

Imatinib Case report

Imatinib

Imatinib Case report

Imatinib

Case report

Ipilimumab/nivolumab

Torasemide Case report

Lithium

Losartan Case report

Losartan

Dystonia Case report

Midazolam

Case report

Mogamulizumab

Naloxone Case report

Naloxone

Melanoma Case report

Nivolumab

Diabetes Case report

Nivolumab

Case report

Nivolumab

Case report

Nivolumab

Diabetes Case report

Nivolumab

Case report

Paclitaxel

Case report

Pamidronic-acid

Case report

Pembrolizumab

Case report

Pembrolizumab

Case report

Pembrolizumab

Case report

Potassium

Gout Case report

Prednisone

Case report

Prednisone

Ramipril Case report

Ramipril

Case report

Retinol

NSCLC Case report

Sintilimab

Erythema Case report

Tepotinib

SCLC Case report

Tislelizumab

Case report

Tozinameran

Tramadol Case report

Tramadol

Tramadol Case report

Tramadol

Case report

Vitamin D

Case report

Vitamin-D

Warfarin Case report

Warfarin

Warfarin Case report

Warfarin

Warfarin Case report

Warfarin

Warfarin Case report

Warfarin